1 Report Excerpts
2 Market Definition
2.1 Scope Of The Study
2.2.1 Research Objectives
2.2.2 Assumptions & Limitations
2.2 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Forecast
3.5 Forecast Model
4 Forecast Indicators
4.1 Drivers
4.2 Restraints
4.3 Opportunity
4.4 Trends
4.5 Macroeconomic Indicators
5 Market Analysis
5.1 Value Chain/Supply Chain Analysis
5.2 Porters' Five Forces Analysis
5.3 Pricing Analysis In (2020-2027)
5.4 Historical Market Analysis (2020-2020)
6 Microfluidic Device, Market Value & Volume Forecast (2020-2027) (USD $Million)
6.1 Introduction
6.2 Microfluidic Device Market (USD $Million) (2020-2020)
6.3 Microfluidic Device Market (USD $Million) (2020-2027)
6.4 Microfluidic Device Market Share Analysis By Price (2020-2020)
6.5 Microfluidic Device Market Units (2020-2020)
6.6 Microfluidic Device Market Units (2020-2027)3
6.8 Microfluidic Device Products Cost Analysis (2020-2020)
6.8 Microfluidic Device Gross Margin Analysis (2020-2020)
7 Microfluidic Device, By Industry Market Value & Volume Forecast (2020-2027) (USD $Million)
7.1 Introduction
7.2 In-Vitro Diagnostics (IVD)
7.2.1 In-Vitro Diagnostics (IVD) (USD $Million) (2020-2020)
7.2.2 In-Vitro Diagnostics (IVD) (USD $Million) (2020-2027)
7.3 Pharmaceuticals
7.3.1 Pharmaceuticals Market (USD $Million) (2020-2020)
7.3.2 Pharmaceuticals Market (USD $Million) (2020-2027)
7.4 Medical Devices
7.4.1 Medical Devices Market (USD $Million) (2020-2020)
7.4.2 Medical Devices Market (USD $Million) (2020-2027)
8 Microfluidic Device, By Application Market Value & Volume Forecast (2020-2027) (USD $Million)
8.1 Introduction
8.2 Point Of Care Testing
8.2.1 Microfluidic Device Market, For Point Of Care Testing (USD $Million) (2020-2020)
8.2.2 Microfluidic Device Market, For Point Of Care Testing (USD $Million) (2020-2027)
8.3 Pharmaceutical And Life Science Research
8.3.1 Microfluidic Device Market, For Pharmaceutical & Life Science Research (USD $Million) (2020-2020)
8.3.2 Microfluidic Device Market, For Pharmaceutical & Life Science Research (USD $Million) (2020-2027)
8.4 Drug Delivery
8.4.1 Microfluidic Device Market, Fort Drug Delivery (USD $Million) (2020-2020)
8.4.2 Microfluidic Device Market, For Drug Delivery (USD $Million) (2020-2027)
8.5 Analytical Devices
8.5.1 Microfluidic Device Market, For Analytical Devices (USD $Million) (2020-2020)
8.5.2 Microfluidic Device Market, For Analytical Devices (USD $Million) (2020-2027)
8.6 Clinical And Veterinary Diagnostics
8.6.1 Microfluidic Device Market, For Clinical & Veterinary Diagnostics, (USD $Million) (2020-2020)
8.6.2 Microfluidic Device Market, For Clinical & Veterinary Diagnostics, (USD $Million) (2020-2027)
8.8 Environmental And Industrial
8.8.1 Microfluidic Device Market, For Environmental And Industrial (USD $Million) (2020-2020)
8.8.2 Microfluidic Device Market, For Environmental And Industrial (USD $Million) (2020-2027)
9 Microfluidic Device, By Material Market Value & Volume Forecast (2020-2027) (USD $Million)
9.1 Glass
9.1.1 Microfluidic Device Market, For Glass (USD $Million) (2020-2020)
9.1.2 Microfluidic Device Market, For Glass (USD $Million) (2020-2027)
9.2 Polymer
9.2.1 Microfluidic Device Market, For Polymer (USD $Million) (2020-2020)
9.2.2 Microfluidic Device Market, For Polymer (USD $Million) (2020-2027)
9.3 Silicon
9.3.1 Microfluidic Device Market, For Silicon (USD $Million) (2020-2020)
9.3.2 Microfluidic Device Market, For Silicon (USD $Million) (2020-2027)
10 Microfluidic Device, By Region Market Value & Volume Forecast (2020-2027) (USD $Million)
10.1 INTRODUCTION
10.2 Y-O-Y GROWTH PROJECTIONS BY Region
10.3 Americas
10.3.1 North America
10.3.1.1 US
10.3.1.2 Canada
10.3.1.3 Mexico
10.3.2 Latin America
10.4 Europe
10.4.1 Western Europe
10.4.1.1 Germany
10.4.1.2 France
10.4.1.3 Italy
10.4.1.4 Spain
10.4.1.5 UK
10.4.1.6 Rest Of Western Europe
10.4.2 Eastern Europe
10.4.2.1 Poland
10.4.2.2 Russia
10.5 Asia
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Rest Of Asia
10.6 Pacific
10.6.1 Australia
10.6.2 New Zealand
10.8 Middle East & Africa
11 COMPANY LANDSCAPE
11.1 Introduction: Key Players
11.2 Commercial Production Date Of Key Manufacturers
11.3 Market Share Analysis
11.4 Product Pictures
11.5 Distributor's List
12 COMPANY PROFILE
12.1 F. Hoffmann-La Roche AG
12.1.1 Overview
12.1.2 Financials
12.1.3 Products & Services
12.1.4 Strategy
12.1.5 Developments
12.2 Abbott Laboratories
12.2.1 Overview
12.2.2 Financials
12.2.3 Products & Services
12.2.4 Strategy
12.2.5 Developments
12.3 Siemens Healthcare GmbH
12.3.1 Overview
12.3.2 Financials
12.3.3 Products & Services
12.3.4 Strategy
12.3.5 Developments
12.4 Agilent Technologies, Inc.
12.4.1 Overview
12.4.2 Financials
12.4.3 Products & Services
12.4.4 Strategy
12.4.5 Developments
12.5 Fluidigm Corporation
12.5.1 Overview
12.5.2 Financials
12.5.3 Products & Services
12.5.4 Strategy
12.5.5 Developments
12.6 Bio-Rad Laboratories, Inc
12.6.1 Overview
12.6.2 Financials
12.6.3 Products & Services
12.6.4 Strategy
12.6.5 Developments
12.8 Cepheid
12.8.1 Overview
12.8.2 Financials
12.8.3 Products & Services
12.8.4 Strategy
12.8.5 Developments
12.8 RainDance Technologies, Inc
12.8.1 Overview
12.8.2 Financials
12.8.3 Products & Services
12.8.4 Strategy
12.8.5 Developments
12.9 Dolomite Centre
12.9.1 Overview
12.9.2 Financials
12.9.3 Products & Services
12.9.4 Strategy
12.9.5 Developments
12.10 Micronit Microfluidics
12.12.1 Overview
12.12.2 Financials
12.12.3 Products & Services
12.12.4 Strategy
12.12.5 Developments
12.11 Johnson & Johnson
12.12.1 Overview
12.12.2 Financials
12.12.3 Products & Services
12.12.4 Strategy
12.12.5 Developments
12.12 Becton, Dickinson And Company
12.12.1 Overview
12.12.2 Financials
12.12.3 Products & Services
12.12.4 Strategy
12.12.5 Developments
13 MRFR Conclusion
14 Appendix
14.1 Discussion Blue Print
14.2 Industry Experts Quotes
14.3 Bibliography